Get the Stockscreener App
14.17
0.70%
-0.10
After Hours:
14.17
Abrdn Life Sciences Investors stock is traded at $14.17, with a volume of 88,961.
It is down -0.70% in the last 24 hours and up +6.06% over the past month.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
See More
Previous Close:
$14.27
Open:
$14.3
24h Volume:
88,961
Relative Volume:
0.84
Market Cap:
$409.12M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.05%
1M Performance:
+6.06%
6M Performance:
+9.25%
1Y Performance:
-5.82%
1-Day Range:
$14.10
$14.30
1-Week Range:
$14.07
$14.38
52-Week Range:
$10.55
$15.68
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Name
Abrdn Life Sciences Investors
Sector
Industry
Phone
-
Address
-
Compare HQL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
14.17 | 407.97M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
10.00 | 3.72B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
38.19 | 3.35B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
22.07 | 2.64B | 0 | 0 | 0 | 0.00 |
|
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
15.94 | 2.51B | 0 | 0 | 0 | 0.00 |
|
UTF
Cohen Steers Infrastructure Fund Inc
|
25.64 | 2.52B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Stock (HQL) Latest News
When is the best time to exit Abrdn Life Sciences InvestorsWeekly Trend Recap & Technical Pattern Based Signals - Newser
Is Abrdn Healthcare Investors reversing from oversold territoryEarnings Growth Summary & AI Driven Stock Movement Reports - Newser
Detecting price anomalies in Abrdn Life Sciences Investors with AIWeekly Trend Report & Low Drawdown Investment Strategies - Newser
Developing predictive dashboards with Abrdn Life Sciences Investors dataJuly 2025 Trade Ideas & Capital Efficient Trading Techniques - Newser
Does Abrdn Healthcare Investors show high probability of reboundWeekly Profit Recap & Safe Entry Trade Reports - Newser
Custom watchlist performance reports with Abrdn Healthcare InvestorsMarket Risk Report & Daily Growth Stock Tips - Newser
Quantitative breakdown of Abrdn Life Sciences Investors recent moveJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - Newser
Has Abrdn Life Sciences Investors formed a bullish divergenceMarket Sentiment Summary & Daily Profit Focused Screening - Newser
Will Abrdn Life Sciences Investors continue its uptrendEarnings Trend Report & High Accuracy Trade Alerts - Newser
Is Abrdn Life Sciences Investors meeting your algorithmic filter criteriaJuly 2025 Action & Risk Managed Trade Strategies - Newser
What to expect from Abrdn Life Sciences Investors in the next 30 daysWeekly Stock Recap & Low Risk Entry Point Guides - Newser
Is Abrdn Life Sciences Investors stock reversal real or fakeEarnings Miss & Long-Term Growth Plans - Newser
Visualizing Abrdn Healthcare Investors stock with heatmaps2025 Price Momentum & Reliable Entry Point Trade Alerts - Newser
How institutional ownership impacts Abrdn Life Sciences Investors stockEarnings Growth Report & Expert-Curated Trade Recommendations - Newser
What high frequency data says about Abrdn Healthcare Investors2025 Market Trends & Daily Growth Stock Investment Tips - Newser
Can Abrdn Life Sciences Investors hit a new high this monthPortfolio Return Report & High Accuracy Swing Entry Alerts - Newser
Tools to monitor Abrdn Life Sciences Investors recovery probability2025 Macro Impact & Low Risk Entry Point Tips - Newser
How to build a dashboard for Abrdn Life Sciences Investors stockJobs Report & Daily Momentum Trading Reports - Newser
Abrdn Life Sciences Investors stock retracement – recovery analysisWeekly Investment Recap & AI Optimized Trading Strategy Guides - Newser
Can trapped investors hope for a rebound in Abrdn Life Sciences InvestorsTrade Signal Summary & Weekly High Return Stock Forecasts - Newser
Momentum divergence signals in Abrdn Life Sciences Investors chartPortfolio Risk Summary & Daily Entry Point Alerts - Newser
Is it too late to sell Abrdn Healthcare InvestorsEarnings Risk Summary & Advanced Technical Analysis Signals - Newser
Real time breakdown of Abrdn Life Sciences Investors stock performance2025 Volume Leaders & Weekly Momentum Picks - Newser
Applying Wyckoff theory to Abrdn Healthcare Investors stockWeekly Investment Summary & Free High Accuracy Swing Entry Alerts - Newser
Is it time to cut losses on Abrdn Healthcare InvestorsJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser
Needham Investment Management LLC Boosts Stake in abrdn Life Sciences Investors $HQL - MarketBeat
Raymond James Financial Inc. Purchases 74,061 Shares of abrdn Life Sciences Investors $HQL - MarketBeat
Risk adjusted return profile for Abrdn Life Sciences Investors analyzedQuarterly Profit Summary & High Accuracy Trade Signal Alerts - Newser
abrdn Life Sciences Investors (NYSE:HQL) Short Interest Down 21.4% in August - MarketBeat
Does Abrdn Life Sciences Investors qualify in momentum factor screeningMarket Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Should you hold or exit Abrdn Healthcare Investors nowJuly 2025 Spike Watch & Stepwise Trade Signal Implementation - Newser
Live market analysis of Abrdn Life Sciences InvestorsMarket Growth Summary & Capital Protection Trading Alerts - Newser
Abrdn Healthcare Investors stock prediction for this week2025 Risk Factors & Smart Money Movement Alerts - Newser
Chart overlay techniques for tracking Abrdn Healthcare Investors2025 Growth vs Value & AI Based Buy/Sell Signal Reports - Newser
Short Interest in abrdn Healthcare Investors (NYSE:HQH) Drops By 25.4% - MarketBeat
Real time social sentiment graph for Abrdn Healthcare Investors2025 Big Picture & Technical Buy Zone Confirmation - Newser
Will Abrdn Life Sciences Investors rebound enough to break evenDollar Strength & High Conviction Investment Ideas - Newser
Can momentum traders help lift Abrdn Life Sciences InvestorsJuly 2025 Final Week & Free Expert Approved Momentum Trade Ideas - Newser
Sentiment analysis tools applied to Abrdn Life Sciences InvestorsMarket Trend Summary & Daily Momentum Trading Reports - Newser
Will Abrdn Life Sciences Investors outperform the marketWeekly Profit Report & Technical Analysis for Trade Confirmation - Newser
Will earnings trigger a reversal in Abrdn Life Sciences Investors2025 Technical Patterns & High Accuracy Swing Entry Alerts - Newser
Smart tools for monitoring Abrdn Life Sciences Investors’s price actionJuly 2025 Institutional & Momentum Based Trading Ideas - Newser
Abrdn Life Sciences Investors Stock (HQL) Financials Data
There is no financial data for Abrdn Life Sciences Investors (HQL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.55%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):